Global Cell and Gene Therapy Manufacturing Market

Global Cell and Gene Therapy Manufacturing Market Size, Share, and COVID-19 Impact By Therapy Type (Cell Therapy, Autologous (patient?s cells), By Gene Therapy (Viral Vector-based, Non-viral Vector-based), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Release Date
Aug 2025
Report ID
DAR1656
Pages
250
Report Format

Global Cell and Gene Therapy Manufacturing Market Overview

  • The Global Cell and Gene Therapy Manufacturing Market Size was worth around?USD 5.705 Billion?in 2023 and is Predicted to Grow to around?USD 60.21 Billion by 2033 with a compound annual growth rate?(CAGR)?of 26.57%?between 2023 and 2033.
  • The market growth is rising due to driven by the development of advanced therapies has been instrumental in revolutionizing the treatment landscape of a number of life-threatening and orphan diseases and in revolutionizing the biopharmaceutical sector.
  • The cell and gene therapy manufacturing market refers to the industry that the therapeutic product process that employs living cells or genetic material to prevent, treat, or cure diseases.

Global Cell and Gene Therapy Manufacturing Market

Major vendors in the global Cell and Gene Therapy Manufacturing industry

Lonza, Bluebird Bio Inc., Catalent Inc., F. Hoffmann-La Roche Ltd., Samsung Biologics, Boehringer Ingelheim, Cellular Therapeutics, Hitachi Chemical Co., Ltd., Bluebird Bio Inc., Takara Bio Inc., Miltenyi Biotec, and Thermo Fisher Scientifi, and others.

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2023 to 2033. Decision Advisors has segmented the Cell and Gene Therapy Manufacturing market based on the below-mentioned segments:

Global Cell and Gene Therapy Manufacturing Market

Global Cell and Gene Therapy Manufacturing Market, By Therapy Type

  • Cell Therapy
  • Autologous (patient’s cells

Global Cell and Gene Therapy Manufacturing Market, By Gene Therapy

  • Non-viral Vector-based
  • Viral Vector-based,

Global Cell and Gene Therapy Manufacturing Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Request Table of Contents:

Check Licence

Choose the plan that fits you best: Single User, Multi-User, or Enterprise solutions tailored for your needs.

Report Details

Pages 250 pages
Delivery PDF & Excel, via Email
Language English
Request Discount  

15% Free Customization

Share your requirements

Request Customization  

We Have You Covered

  • 24/7 Analyst Support
  • Clients Across the Globe
  • Tailored Insights
  • Technology Tracking
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Studies
  • Market Overview
  • Market Segmentation
  • Growth Drivers
  • Market Opportunities
  • Regulatory Insights
  • Innovation & Sustainability

Report Details

Pages 250
Delivery PDF & Excel via Email
Language English
Release Aug 2025
Access Download from this page
Request Sample